Skip to main content
Log in

What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purposes

Acute exacerbation of interstitial pneumonia (AEIP) is a leading cause of death after lung cancer resection in patients with interstitial lung disease.

Methods

We retrospectively analyzed 1763 patients with non-small cell lung cancer with a clinical diagnosis of interstitial lung disease (ILD) who underwent lung cancer resection between 2000 and 2009 at 61 hospitals in Japan. AEIP occurred in 164 of 1763 (9.3%) patients with a mortality rate of 43.9% (72/164). Univariate and multivariate analyses were carried out to identify possible risk factors of fatal AEIP. We then analyzed the 164 patients who developed postoperative AEIP and identified the preoperative and postoperative risk factors.

Results

A multivariate regression analysis identified that the sex, percent vital capacity, neoadjuvant radiation, preoperative history of AEIP, preoperative use of steroids, usual interstitial pneumonia pattern on CT, and surgical procedures were independent preoperative risk factors for death due to AEIP. ILD patients with emphysema somehow showed a lower risk of fatal AEIP than those without emphysema in this study.

Conclusions

This study revealed eight risk factors for fatal AEIP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: The overall survival.
Fig. 2: The overall survival after overcoming AEIP.

Similar content being viewed by others

Abbreviations

IIP:

Idiopathic interstitial pneumonia

IPF:

Idiopathic pulmonary fibrosis

AEIP:

Acute exacerbation of interstitial pneumonia

KL-6:

Sialylated carbohydrate antigen KL-6

UIP:

Usual interstitial pneumonia

ILD:

Interstitial lung disease

CT:

Computed tomography

CRP:

Serum C-reactive protein

LDH:

Lactate dehydrogenase

CEA:

Carcinoembryonic antigen

%VC:

Percent vital capacity

FEV1%:

Percent forced expiratory volume in 1 s

VATS:

Video-assisted thoracoscopic surgery

CTx:

Chemotherapy

RTx:

Radiotherapy

References

  1. American Thoracic Society and European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med. 2000;161:646–64.

    Article  Google Scholar 

  2. Kumar P, Goldstraw P, Yamada K, Nicholson AG, Wells AU, Hansell DM, et al. Pulmonary fibrosis and lung cancer: risk and benefit analyses of pulmonary resection. J Thorac Cardiovasc Surg. 2003;125:1321–7.

    Article  CAS  PubMed  Google Scholar 

  3. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, et al. The idiopathic pulmonary fibrosis clinical research network I. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636–43.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Utz JP, Ryu JH, Douglas WW, Hartman TE, Tazelaar HD, Myers JL, et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J. 2001;17:175–9.

    Article  CAS  PubMed  Google Scholar 

  5. Martinod E, Azorin JF, Sadoun D, Destable MD, Le Toumelin P, Longchampt E, et al. Surgical resection of lung cancer in patients with underlying interstitial lung disease. Ann Thorac Surg. 2002;74:1004–7.

    Article  PubMed  Google Scholar 

  6. Watanabe A, Higami T, Ohori S, Koyanagi T, Nakashima S, Mawatari T. Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? J Thorac Cardiovasc Surg. 2008;136:1357–63.

    Article  PubMed  Google Scholar 

  7. Watanabe A, Miyajima M, Mishina T, Nakazawa J, Harada R, Kawaharada N, et al. Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis. Gen Thorac Cardiovasc Surg. 2013;61:254–61.

    Article  PubMed  Google Scholar 

  8. Sato T, Teramukai S, Kondo H, Watanabe A, Ebina M, Kishi K, et al. Japanese Association for Chest Surgery. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg. 2014;147:1604–11.

    Article  PubMed  Google Scholar 

  9. Sato T, Watanabe A, Kondo H, Kanzaki M, Okubo K, Yokoi K, et al. Japanese Association for Chest Surgery. Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases. J Thorac Cardiovasc Surg. 2015;149:64–70.

    Article  PubMed  Google Scholar 

  10. Sato T, Kondo H, Watanabe A, Nakajima J, Niwa H, Horio H, et al. A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients. Gen Thorac Cardiovasc Surg. 2015;63:164–72.

    Article  PubMed  Google Scholar 

  11. The Japanese Respiratory Society. Idiopathic interstitial pneumonias: diagnosis and treatment. 2nd ed. Tokyo: Nankodo; 2011.

    Google Scholar 

  12. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yoshimura K, Nakatani T, Nakamori Y, Chonabayashi N, Tachibana A, Nakata K, et al. Acute exacerbation in idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai zasshi. 1984;22:1012–20.

    CAS  PubMed  Google Scholar 

  14. Panos RJ, Mortenson RL, Niccoli SA, King TE Jr. Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med. 1990;88:396–404.

    Article  CAS  PubMed  Google Scholar 

  15. Song JW, Hong SB, Lim CM, Koh Y, Kim DS. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur Respir J. 2011;37:356–63.

    Article  CAS  PubMed  Google Scholar 

  16. Minegishi Y, Takenaka K, Mizutani H, Sudoh J, Noro R, Okano T, et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Int Med. 2009;48:665–72.

    Article  Google Scholar 

  17. King TE Jr, Tooze JA, Schwarz MI, Brown K, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis. Scoring system and survival model. Am J Respir Crit Care Med. 2001;164:1171–81.

    Article  PubMed  Google Scholar 

  18. Schwartz DA, Helmers RA, Galvin JR, Van Fossen DS, Frees KL, Dayton CS, et al. Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1994;149:450–4.

    Article  CAS  PubMed  Google Scholar 

  19. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538–42.

    Article  PubMed  Google Scholar 

  20. Richeldi L, Davies HR, Ferrara G, Franco F. Corticosteroids for idiopathic pulmonary fibrosis. Cochrane Database Syst Rev. 2003;3:CD002880.

    Google Scholar 

  21. Sumikawa H, Johkoh T, Fujimoto K, Arakawa H, Colby TV, Fukuoka J, et al. Pathologically proved nonspecific interstitial pneumonia: CT pattern analysis as compared with usual interstitial pneumonia CT pattern. Radiology. 2014;272(2):549–56.

    Article  PubMed  Google Scholar 

  22. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Groupe d’Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct under-recognised entity. Eur Respir J. 2005;26:586–93.

    Article  CAS  PubMed  Google Scholar 

  23. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144:234–40.

    Article  PubMed  Google Scholar 

  24. Hyzy R, Huang S, Myers J, Flaherty K, Martinez F. Acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2007;132:1652–8.

    Article  PubMed  Google Scholar 

  25. Collard R, Ryerson J, Corte J, Jenkins G, Kondoh Y, Lederer J, et al. Acute exacerbation of idiopathic pulmonary fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016;194:265–75.

    Article  CAS  PubMed  Google Scholar 

  26. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 2002;165:378–81.

    Article  PubMed  Google Scholar 

  27. Chiyo M, Sekine Y, Iwata T, Tatsumi K, Yasufuku K, Iyoda A, et al. Impact of interstitial lung disease on surgical morbidity and mortality for lung cancer: analyses of short-term and long-term outcomes. J Thorac Cardiovasc Surg. 2003;126:1141–6.

    Article  PubMed  Google Scholar 

  28. Koizumi K, Hirata T, Hirai K, Mikami I, Okada D, Yamagishi S, et al. Surgical treatment of lung cancer combined with interstitial pneumonia: the effect of surgical approach on postoperative acute exacerbation. Ann Thorac Cardiovasc Surg. 2004;10:340–6.

    PubMed  Google Scholar 

  29. Watanabe A, Kawaharada N, Higami T. Postoperative acute exacerbation of IPF after lung resection for primary lung cancer. Pulm Med. 2011;2011:960316.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kishaba T, Tamaki H, Shimaoka Y, et al. Staging of acute exacerbation in patients with idiopathic pulmonary fibrosis. Lung. 2014;192:141–9.

    Article  PubMed  Google Scholar 

  31. Fujimoto T, Okazaki T, Matsukura T, et al. Operation for lung cancer in patients with idiopathic pulmonary fibrosis: surgical contraindication? Ann Thorac Surg. 2003;76:1674–9.

    Article  PubMed  Google Scholar 

  32. Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2005;171:1040–7.

    Article  PubMed  Google Scholar 

  33. Iwata T, Yoshida S, Nagato K, et al. Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis. Surg Today. 2015;45:1263–70.

    Article  PubMed  Google Scholar 

  34. Kubo H, Nakayama K, Yanai M, et al. Anticoagulant therapy for idiopathic pulmonary fibrosis. Chest. 2005;128:1475–82.

    Article  CAS  PubMed  Google Scholar 

  35. Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35:821–9.

    Article  CAS  PubMed  Google Scholar 

  36. Stern JB, Mal H, Groussard O, et al. Prognosis of patients with advanced idiopathic pulmonary fibrosis requiring mechanical ventilation for acute respiratory failure. Chest. 2001;120:213–9.

    Article  CAS  PubMed  Google Scholar 

  37. Yokoyama T, Kondoh Y, Taniguchi H, et al. Non-invasive ventilation in acute exacerbation of idiopathic pulmonary fibrosis. Intern Med. 2010;49:1509–14.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms. Tomoko Sonoda of Sapporo Medical University and Ms. Tomomi Sakabayashi of Kyoto Prefectural University of Medicine for their contribution to the statistical analysis and assessment of the patients’ clinical data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masahiro Miyajima.

Ethics declarations

Conflict of interest statement

Masahiro Miyajima and the other co-authors have no conflicts of interest to declare in association with this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyajima, M., Watanabe, A., Sato, T. et al. What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?. Surg Today 48, 404–415 (2018). https://doi.org/10.1007/s00595-017-1605-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-017-1605-8

Keywords

Navigation